HOME >> MEDICINE >> NEWS
Mistletoe is not an anti-cancer drug, say doctors

The belief that mistletoe can help treat cancer is a myth which can cause harm, warn doctors in this week's Christmas issue of the BMJ.

The warning follows the case of a cancer patient who attended hospital with a tumour-like growth under the skin induced by mistletoe.

Some patients with cancer inject themselves mistletoe extract in the hope of improving their condition, writes complementary medicine expert, Professor Edzard Ernst in an accompanying editorial. In continental Europe, at least 30 different mistletoe preparations are available and in Germany, the insurance system pays for this treatment. A Google search also showed that 145,000 websites promote or mention mistletoe as a treatment for cancer.

So, is mistletoe an effective anticancer drug and how safe is it?

The theory that mistletoe might help treat cancer is based on the fact that, like cancer, mistletoe is a parasitic growth that eventually kills its host, says Ernst. Despite the implausibility of this idea, studies have shown that mistletoe or its main constituents do have anticancer activity. However, many plants have some sort of anticancer activity, but in most cases the compounds cannot be used.

Proponents claim that regular injections of mistletoe extract improve the natural course of cancer by slowing down or stopping tumour growth and improve quality of life.

Yet a wide range of serious adverse reactions have been noted, such as anaphylaxis, breathing difficulties, joint pain and kidney failure. Some studies even suggest that mistletoe extract may enhance the proliferation of some cancers.

So the claim that mistletoe injections have no serious risks is misleading, argues Ernst.

Mistletoe has been tested extensively as a treatment for cancer, but the most reliable trials fail to show benefit, and some reports show considerable potential for harm. The costs of regular mistletoe injections are also high.

'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
21-Dec-2006


Page: 1 2

Related medicine news :

1. New algorithm matches any tumor cells to best possible anti-cancer treatments
2. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
3. Vorinostat shows anti-cancer activity in recurrent gliomas
4. Research says boiling broccoli ruins its anti-cancer properties
5. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
6. Erectile dysfunction drugs heighten natural anti-cancer activity
7. New litmus test could aid discovery of anti-cancer drugs
8. Derivatives of cannabis for anti-cancer treatment win Kaye Award for Hebrew University student
9. Risks outweigh benefits of shark cartilage as anti-cancer treatment
10. New method of administering anti-cancer drug may be more effective, safer
11. Innovative study finds way to bio-synthesize an anti-cancer compound

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mistletoe not anti cancer drug say doctors

(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... 2015 Vancouver personal injury lawyers at Jiwa ... affected by time limits. They stated that in many cases, ... or even nullify it. Many a time, delays in making ... rights under BC law. As a result, experts at Jiwa ... should consult a personal injury lawyer in order to know ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Indosoft ... software suite for Asterisk, are pleased to announce the ... successful 5.7 and 5.8 versions of Q-Suite, this new ... as a number of new features to the leading ... 2015. , Q-Suite 5.9 will add features to enhance ...
(Date:2/28/2015)... A study out of the University of Oxford ... the treatment of a hereditary ocular condition that leads ... Dr. Robert MacLaren, professor of ophthalmology at the University ... on January 16, 2014 , the study treated six ... mostly affects men and leads to the degeneration of ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
(Date:2/27/2015)... 2015 Roughly three-quarters of pharmacists said ... an interchangeable biosimilar for its branded biologic counterpart ... name, according to a survey published in the ... of Managed Care & Specialty Pharmacy (JMCP). ... pharmacists would feel as confident if the products ...
(Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
(Date:2/27/2015)... 27, 2015 The role of the Medical ... one thing hasn,t changed: face-to-face meetings are seen as ... Key Opinion Leaders. Yet at the same ... type of interaction, field medical teams within the pharmaceutical ... This is just one of the challenges addressed in ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2
Cached News: